# University of Colorado Boulder 1002176349

Anti-ILF3 antibody [EPR3626]; Anti-ILF2/NF45 antibody [EPR10694(B)]; Anti-PD-L1 antibody [RM1012]

**Recipient:** ABCAM Inc.

**Award Amount:** $2,260.00
**Ceiling:** $2,260.00

**Awarded:** August 14, 2025

**Identifier:** 1002176349

This purchase order, issued by the University of Colorado Boulder, a public college or university in Colorado, USA, awarded on August 14, 2025, to ABCAM Inc. includes the procurement of three antibody products: Anti-ILF3 antibody [EPR3626], Anti-ILF2/NF45 antibody [EPR10694(B)], and Anti-PD-L1 antibody [RM1012]. The total obligated and award amount is $2,260. The order covers 1 unit each of the first two antibodies and 2 units of the third, with unit prices of $580, $590, and $545 respectively. The award aims to support research activities and involves no specified contract end date. The purchase involves a single transaction for laboratory research reagents, likely under a research contract. The award is located at the university campus in Boulder, Colorado.

### Description

Anti-ILF3 antibody [EPR3626]; Anti-ILF2/NF45 antibody [EPR10694(B)]; Anti-PD-L1 antibody [RM1012]
